Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Ossium Health, Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Baylor College of Medicine
Cedars-Sinai Medical Center
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
West Virginia University
Northside Hospital, Inc.
Tessa Therapeutics
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center